Clinical Trials Directory

Trials / Conditions / Other Cancer

Other Cancer

18 registered clinical trials studyying Other Cancer4 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingA Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching an
NCT06397651
Complement Theory Inc.N/A
RecruitingLocally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
NCT06103669
University of California, DavisN/A
CompletedEvaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy
NCT05176860
Varian, a Siemens Healthineers CompanyN/A
RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750
PMV Pharmaceuticals, IncPhase 1 / Phase 2
UnknownThe Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
NCT04591431
Fondazione per la Medicina PersonalizzataPhase 2
CompletedAdvance Care Planning: Promoting Effective and Aligned Communication in the Elderly
NCT03609177
Dana-Farber Cancer InstituteN/A
CompletedSymptom Management Implementation of Patient Reported Outcomes in Oncology
NCT03850912
Dana-Farber Cancer InstituteN/A
CompletedPilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
NCT03638453
Dana-Farber Cancer InstituteN/A
Active Not RecruitingRuxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (H
NCT03674047
Massachusetts General HospitalPhase 2
CompletedA Geriatric Oncology Collaborative Care Intervention for Older Adults With Advanced Cancer
NCT03721926
Massachusetts General HospitalN/A
CompletedMultimodal Mobile Intervention Application (App) to Address Sexual Dysfunction in Hematopoietic Stem Cell Tran
NCT03967379
Massachusetts General HospitalN/A
CompletedTesting Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals
NCT03736746
Dana-Farber Cancer InstituteN/A
CompletedSHARE (Sharing Goals and Preferences) Study
NCT03392090
Dana-Farber Cancer InstituteN/A
CompletedShared Care: Patient-Centered Management After Hematopoietic Cell Transplantation
NCT03244826
Dana-Farber Cancer InstituteN/A
RecruitingDiscovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients
NCT04340024
National Cancer Centre, Singapore
UnknownCirculating Tumor DNA Exposure in Peripheral Blood
NCT03517332
Quantgene Inc.
Active Not RecruitingDevelopment of an Intervention to Enhance Cancer Pain Management
NCT03752268
Massachusetts General HospitalN/A
RecruitingGenetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
NCT03160274
The University of Texas Health Science Center at San Antonio